What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
His primary scientific interests are in Psychiatry, Major depressive disorder, Depression, Internal medicine and Clinical psychology.
His Psychiatry research is multidisciplinary, relying on both Placebo and Clinical trial.
He has researched Major depressive disorder in several fields, including Venlafaxine, Citalopram, STAR*D and Randomized controlled trial.
Maurizio Fava focuses mostly in the field of Depression, narrowing it down to topics relating to Mood and, in certain cases, Mood disorders and Bipolar disorder.
His Internal medicine research includes elements of Antidepressant and Endocrinology.
The various areas that Maurizio Fava examines in his Clinical psychology study include Atypical depression, Personality Assessment Inventory and Age of onset.
His most cited work include:
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2853 citations)
- Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice (2525 citations)
- A mega-analysis of genome-wide association studies for major depressive disorder (882 citations)
What are the main themes of his work throughout his whole career to date?
Maurizio Fava mainly investigates Psychiatry, Major depressive disorder, Depression, Internal medicine and Antidepressant.
His Psychiatry research focuses on subjects like Clinical psychology, which are linked to Irritability.
As a part of the same scientific family, Maurizio Fava mostly works in the field of Major depressive disorder, focusing on Randomized controlled trial and, on occasion, Escitalopram.
His study in Depression focuses on STAR*D in particular.
Maurizio Fava combines subjects such as Placebo and Endocrinology with his study of Internal medicine.
His work deals with themes such as Discontinuation and Bupropion, which intersect with Antidepressant.
He most often published in these fields:
- Psychiatry (52.38%)
- Major depressive disorder (51.74%)
- Depression (45.33%)
What were the highlights of his more recent work (between 2016-2021)?
- Major depressive disorder (51.74%)
- Internal medicine (37.27%)
- Depression (45.33%)
In recent papers he was focusing on the following fields of study:
Maurizio Fava mostly deals with Major depressive disorder, Internal medicine, Depression, Placebo and Antidepressant.
In his study, Irritability, Neuroticism and Neuroimaging is inextricably linked to Clinical psychology, which falls within the broad field of Major depressive disorder.
His Internal medicine study combines topics in areas such as Endocrinology and Cardiology.
Depression is a subfield of Psychiatry that Maurizio Fava studies.
He integrates Psychiatry and In patient in his studies.
His studies in Placebo integrate themes in fields like Serotonin reuptake inhibitor, Randomized controlled trial, Adjunctive treatment and Sertraline.
Between 2016 and 2021, his most popular works were:
- Harmonization of cortical thickness measurements across scanners and sites. (199 citations)
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (97 citations)
- Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data. (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
Maurizio Fava focuses on Major depressive disorder, Depression, Placebo, Internal medicine and Antidepressant.
Maurizio Fava has included themes like Suicidal ideation, Adverse effect, Functional connectivity and Anxiety in his Major depressive disorder study.
Depression is a subfield of Psychiatry that Maurizio Fava investigates.
His studies deal with areas such as Alternative medicine, Social psychology and Suicide attempt as well as Psychiatry.
His Placebo research includes themes of Anesthesia, Randomized controlled trial, Clinical trial and Sertraline.
His biological study spans a wide range of topics, including Esketamine, Placebo-controlled study and Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
